Literature DB >> 26733367

Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.

Y Otowa1, T Nakamura2, G Takiguchi2, M Yamamoto2, S Kanaji2, T Imanishi3, T Oshikiri2, S Suzuki2, K Tanaka4, Y Kakeji2.   

Abstract

BACKGROUND: Enhancements in surgical techniques have led to improved outcomes for esophageal cancer. Recent findings have showed that esophageal cancer is frequently associated with multiple primary cancers, and surgical resection is usually complicated in such cases. The aim of this study was to clarify the clinical significance of surgery for patients with esophageal squamous cell cancer associated with multiple primary cancers.
METHODS: The clinical outcomes of surgical resection for esophageal cancer were compared among 79 patients with antecedent and/or synchronous cancers (Multiple cancer group) and 194 patients without antecedent and/or synchronous cancers (Single cancer group).
RESULTS: The most common site of multiple primary cancers was the pharynx (36 patients; 29.7%), followed by the stomach (24 patients; 19.8%). The reconstruction method was more complicated in the Multiple cancer group as a result of the prolonged surgery time and increased blood loss. However, postoperative morbidity and overall survival (OS) did not differ between the two groups. After esophagectomy, metachronous cancers were observed in 26 patients, with 30 regions in total, and 93.1% were found to be curable. Sex was the only independent risk factors for developing metachronous cancer after esophagectomy.
CONCLUSIONS: The presence of antecedent and synchronous cancers complicates the surgical resection of esophageal cancer; however, no differences were found in the OS and postoperative morbidity between the two groups. Therefore, surgical intervention should be selected as a first-line treatment. Because second primary cancers are often observed in esophageal cancer, we recommend a close follow-up using esophagogastroduodenoscopy and contrast-enhanced computed tomography.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; Esophagectomy; Multiple primary cancer; Squamous cell carcinoma

Mesh:

Year:  2015        PMID: 26733367     DOI: 10.1016/j.ejso.2015.11.012

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

1.  Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis.

Authors:  Laurelle van Tilburg; Steffi E M van de Ven; Manon C W Spaander; Laurens A van Kleef; Robin Cornelissen; Marco J Bruno; Arjun D Koch
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-23       Impact factor: 4.553

2.  Better Prognosis and Survival in Esophageal Cancer Survivors After Comorbid Second Primary Malignancies: A SEER Database-Based Study.

Authors:  Jiayue Ye; Sheng Hu; Wenxiong Zhang; Deyuan Zhang; Yang Zhang; Dongliang Yu; Jinhua Peng; Jianjun Xu; Yiping Wei
Journal:  Front Surg       Date:  2022-05-06

3.  Long-Term Prognostic Predictors of Esophageal Squamous Cell Carcinoma Potentially Indicated for Endoscopic Submucosal Dissection.

Authors:  Tomohiko Suzuki; Kazuhiro Furukawa; Kohei Funasaka; Eri Ishikawa; Tsunaki Sawada; Keiko Maeda; Takeshi Yamamura; Takuya Ishikawa; Eizaburo Ohno; Masanao Nakamura; Hiroki Kawashima; Ryoji Miyahara; Mitsuhiro Fujishiro
Journal:  Digestion       Date:  2020-09-07       Impact factor: 3.216

4.  Chemoradiotherapy for Synchronous Multiple Primary Cancers with Esophageal Squamous Cell Carcinoma: a Case-control Study.

Authors:  Qi-Wen Li; Yu-Jia Zhu; Wen-Wen Zhang; Han Yang; Yao Liang; Yong-Hong Hu; Bo Qiu; Meng-Zhong Liu; Hui Liu
Journal:  J Cancer       Date:  2017-02-11       Impact factor: 4.207

5.  Germline BRCA2 Truncating Mutation in Familial Esophageal Squamous Cell Carcinoma: A Case Controlled Study in China.

Authors:  Zhong Liang; Weidong Hu; Shuping Li; Zhenhong Wei; Zijiang Zhu
Journal:  Med Sci Monit       Date:  2020-06-24

6.  Conventional Western Treatment Associated With Chinese Herbal Medicine Ameliorates the Incidence of Head and Neck Cancer Among Patients With Esophageal Cancer.

Authors:  Chia-Chen Chang; Kuo-Wei Bi; Hung-Jen Lin; Yuan-Chih Su; Wen-Ling Wang; Chen-Yuan Lin; Chun-Fu Ting; Mao-Feng Sun; Sheng-Teng Huang
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

7.  Curative resection of advanced esophageal cancer with metachronous stage IV breast cancer: A case report.

Authors:  Yusuke Gokon; Tadashi Sakurai; Fumiyoshi Fujishima; Yusuke Taniyama; Takahiro Heishi; Hiroshi Okamoto; Shota Maruyama; Hirotaka Ishida; Yu Onodera; Hironobu Sasano; Takashi Kamei
Journal:  Int J Surg Case Rep       Date:  2018-03-19

8.  Staging resection of multiple primary esophageal cancer by endoscopic submucosal dissection and esophagectomy: A case report.

Authors:  Yufeng Yao; Yimin Wu; Ying Chai
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

9.  Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma.

Authors:  Guoqing Zhang; Bin Wu; Xiaofei Wang; Jindong Li
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

10.  Clinicopathological features and prognosis of patients with esophageal cancer as the second primary cancer: a large population-based analysis using the SEER program [2000-2015].

Authors:  Zhencong Chen; Ming Li; Ke Ma; Zhengyang Hu; Shuai Wang; Hongyu Chen; Yuansheng Zheng; Cheng Zhan; Zongwu Lin; Qun Wang
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.